Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lord Abbett Developing Growth Fund Class I (LADYX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter. To pursue its objective, the fund invests primarily in the common stocks of companies demonstrating above-average, long-term growth potential. The fund invests at least 65% of its net assets in equity securities of small companies. In selecting investments, it may invest in U.S. and foreign (including emerging market) companies.


1 month+3.82% 3 years+17.43%
3 months-3.01% 5 years+12.74%
1 year-3.47% Since inception+7.85%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+12.74%+12.11%
Expense ratio0.73%1.37%
Risk 5 year sharpe ratio0.810.78
Net assets$3.1B$770.2M
Average market cap$2.4B$2.8B
Average P/E29.926.9
Portfolio turnover186%186%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyLord Abbett
Fund manager & tenureF. O’Halloran, III / 13 Years
Minimal initial investment$1,000,000.00
Minimum IRA investment--


U.S. stock92.61%
International stock2.40%
Fixed income0.22%
Top 5 Sectors
Portfolio weighting
Healthcare 15.78%
Industrial materials 12.87%
Hardware 10.98%
Consumer goods 9.38%
Business service 9.03%
Top 10 Holdings
Portfolio weighting
BWLD Buffalo Wild Wings Inc2.30%
TWOU 2U Inc2.15%
ULTI Ultimate Software Group Inc2.06%
MKTX Marketaxess Holdings Inc1.77%
PNRA Panera Bread Co1.72%
RH Restoration Hardware Holdings Inc1.69%
ZLTQ ZELTIQ Aesthetics Inc1.60%
PBH Prestige Brands Holdings Inc1.55%
CASY Caseys General Stores Inc1.53%
ABMD Abiomed Inc1.50%